ROPIVACAINE ACTAVIS 0.5% (w/v) ropivacaine hydrochloride (as monohydrate) 100 mg/20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

ropivacaine actavis 0.5% (w/v) ropivacaine hydrochloride (as monohydrate) 100 mg/20 ml solution for injection ampoule

medis pharma pty ltd - ropivacaine hydrochloride monohydrate, quantity: 105.8 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - surgical anaesthesia (adults and children over 12 years of age),? epidural block for surgery including caesarean section,? intrathecal anaesthesia,? field block (minor nerve block and infiltration),? major nerve block,analgesia (adults and children over 12 years of age),? continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain,? field block (minor nerve block and infiltration),? continuous peripheral nerve block infusion or intermittent injections for post operative pain management,? continuous wound infusion for postoperative pain management (adults only),analgesia (children aged 0 - 12 years),? caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years,? continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years,? peripheral nerve block in children aged 1 up to and including 12 years,for peri- and postoperative pain management.,there are no safety or efficacy data to support the use of ropivacaine actavis for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections and for continuous wound infusion support the use for up to 48 hours only).

Mepidor 20 mg/ml solution for injection for horses Ireland - English - HPRA (Health Products Regulatory Authority)

mepidor 20 mg/ml solution for injection for horses

vetviva richter gmbh - mepivacaine hydrochloride - solution for injection - mepivacaine

Oxycodone Juno oxycodone hydrochloride 200 mg / 20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 200 mg / 20 ml solution for injection ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 200 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

Oxycodone Juno oxycodone hydrochloride 20 mg / 2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 20 mg / 2 ml solution for injection ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

Oxycodone Juno oxycodone hydrochloride 10 mg / 1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone juno oxycodone hydrochloride 10 mg / 1 ml solution for injection ampoule

juno pharmaceuticals pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WKT oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wkt oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium hydroxide; water for injections; sodium chloride; sodium citrate; hydrochloric acid - oxycodone wkt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WKT oxycodone hydrochloride 10 mg/1 mL solution for injection or infusion glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wkt oxycodone hydrochloride 10 mg/1 ml solution for injection or infusion glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium citrate; sodium hydroxide; sodium chloride; hydrochloric acid; citric acid monohydrate - oxycodone wkt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WOCKHARDT oxycodone hydrochloride 20 mg/2 mL solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wockhardt oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium citrate; water for injections; citric acid monohydrate; sodium hydroxide - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WOCKHARDT oxycodone hydrochloride 10 mg/1 mL solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wockhardt oxycodone hydrochloride 10 mg/1 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; citric acid monohydrate; water for injections; sodium chloride; sodium hydroxide; sodium citrate - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hydralazine link hydralazine hydrochloride 20 mg/1 ml solution for injection vial

link medical products pty ltd t/a link pharmaceuticals - hydralazine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; propylene glycol - hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia).